176 related articles for article (PubMed ID: 3158727)
21. Quantification of in vivo distribution of platelets labeled with indium-111 oxine.
Heyns AD; Lötter MG; Kotzé HF; Pieters H; Wessels P
J Nucl Med; 1982 Oct; 23(10):943-4. PubMed ID: 6811705
[No Abstract] [Full Text] [Related]
22. Indium-111 tropolone, a new high-affinity platelet label: preparation and evaluation of labeling parameters.
Dewanjee MK; Rao SA; Didisheim P
J Nucl Med; 1981 Nov; 22(11):981-7. PubMed ID: 7299484
[TBL] [Abstract][Full Text] [Related]
23. Chemotoxicity of indium-111 oxine in mammalian cells.
Kassis AI; Adelstein SJ
J Nucl Med; 1985 Feb; 26(2):187-90. PubMed ID: 3918148
[TBL] [Abstract][Full Text] [Related]
24. Platelet regeneration time after aspirin ingestion and platelet survival time after labelling with 51chromium or 111indium oxine--a comparative study.
Boneu A; Sié P; Bugat R; Caranobe C; Eber M; Cazenave JP; Boneu B
Thromb Haemost; 1985 Apr; 53(2):260-3. PubMed ID: 3927506
[TBL] [Abstract][Full Text] [Related]
25. Radiolabeled leukocytes and platelets.
Datz FL
Invest Radiol; 1986 Mar; 21(3):191-200. PubMed ID: 3082790
[TBL] [Abstract][Full Text] [Related]
26. Cell damage resulting from the labeling of rat lymphocytes and HeLa S3 cells with In-111 oxine.
Chisholm PM; Danpure HJ; Healey G; Osman S
J Nucl Med; 1979 Dec; 20(12):1308-11. PubMed ID: 119830
[TBL] [Abstract][Full Text] [Related]
27. Contribution of contaminant indium-114m/indium-114 to indium-111 oxine blood dosimetry.
Marcus CS; Stabin MG; Watson EE; Kuperus JH
J Nucl Med; 1985 Sep; 26(9):1091-3. PubMed ID: 3928839
[TBL] [Abstract][Full Text] [Related]
28. A study of lymphocyte kinetics in nasopharyngeal carcinoma with indium III oxine-labelled lymphocytes.
Cheng PN; Shiu WC; Leung JO; Ho SK; Wong KK; Metreweli C
Clin Exp Immunol; 1988 Dec; 74(3):398-403. PubMed ID: 3148379
[TBL] [Abstract][Full Text] [Related]
29. Should platelets be radiolabelled in plasma medium?
Tsan MF; Hill-Zobel RL
Am J Hematol; 1987 Jul; 25(3):355-9. PubMed ID: 3111252
[TBL] [Abstract][Full Text] [Related]
30. The molecular structure of indium oxine.
Green MA; Huffman JC
J Nucl Med; 1988 Mar; 29(3):417-20. PubMed ID: 3126280
[TBL] [Abstract][Full Text] [Related]
31. Endothelial cell labeling with indium-111-oxine as a marker of cell attachment to bioprosthetic surfaces.
Sharefkin JB; Lather C; Smith M; Rich NM
J Biomed Mater Res; 1983 Mar; 17(2):345-57. PubMed ID: 6221015
[TBL] [Abstract][Full Text] [Related]
32. [Effect of anti-inflammatory drugs on transformation of human T-lymphocytes to blast-like cells induced by PHA and on one-way mixed lymphocyte reaction].
Oshizawa T; Hayakawa T; Yamamura M
Eisei Shikenjo Hokoku; 1984; (102):36-9. PubMed ID: 6241839
[No Abstract] [Full Text] [Related]
33. In vivo red blood cell compatibility testing using indium-113m tropolone-labeled red blood cells.
Morrissey GJ; Gravelle D; Dietz G; Driedger AA; King M; Cradduck TD
J Nucl Med; 1988 May; 29(5):684-8. PubMed ID: 3373305
[TBL] [Abstract][Full Text] [Related]
34. In vivo effect of DDS on phytohemagglutinin (PHA)-induced lymphocyte transformation cultures in normal healthy volunteers.
Sengupta U; Ghei SK; Venkatesan K; Bharadwaj VP
Int J Lepr Other Mycobact Dis; 1979 Jun; 47(2):167-70. PubMed ID: 572351
[TBL] [Abstract][Full Text] [Related]
35. Restrictions to the use of 111 indium-oxine as a radiolabel in lymphocyte migration studies.
Van Dinther-Janssen AC; Scheper RJ
J Immunol Methods; 1981; 46(3):353-60. PubMed ID: 6796624
[TBL] [Abstract][Full Text] [Related]
36. A quantitative study of indium-111-oxine platelet kinetics in acute and chronic renal transplant rejection.
Heyns AD; Lötter MG; Pieters H; Pauw FH; Badenhorst PN; Wessels P; Minnaar PC
Clin Nephrol; 1982 Oct; 18(4):174-82. PubMed ID: 6814802
[TBL] [Abstract][Full Text] [Related]
37. [111In]oxine labelling of polymorphonuclear leucocytes: doubts concerning elution and effects on cell behaviour.
Sheehan NJ; Brown KA; Camacho A; Dumonde DC
Int J Nucl Med Biol; 1985; 12(3):243-7. PubMed ID: 3934095
[TBL] [Abstract][Full Text] [Related]
38. Cytotoxicity of some indium radiopharmaceuticals in mouse testes.
Rao DV; Sastry KS; Grimmond HE; Howell RW; Govelitz GF; Lanka VK; Mylavarapu VB
J Nucl Med; 1988 Mar; 29(3):375-84. PubMed ID: 3126279
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of mitogen and specific antigen-induced human lymphocyte proliferation by cadmium.
Kastelan M; Gerencer M; Kastelan A; Gamulin S
Exp Cell Biol; 1981; 49(1):15-9. PubMed ID: 6450068
[TBL] [Abstract][Full Text] [Related]
40. Kinetic studies of lymphocytes labeled with indium-111-oxine in patients with malignant lymphoma.
Matsuda S; Uchida T; Kariyone S
Fukushima J Med Sci; 1986 Jun; 32(1):39-46. PubMed ID: 3104181
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
